Reaction

Breast Reconstruction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 372 reports · 3 co-occurring drugs

As of the last recalculation, Breast Reconstruction appears in 372 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is MEDROXYPROGESTERONE ACETATE (PRR 36.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Medroxyprogesterone Acetate3036.636.6
Conjugated Estrogens And Medroxyprogesterone Acetate1126.826.9
Ado-Trastuzumab Emtansine426.826.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.